Skip to main content
Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Effect of the SARS-CoV-2 pandemic on metabolic control in patients with type 2 diabetes: a 5-year cohort follow-up managed by a dynamic multidisciplinary team in Northeastern Mexico

Fig. 1

Proportion of subjects in metabolic control from 2018 to 2022. Glycated Hemoglobin considered adequately controlled when < 7%, < 7.5% in adults over 65, and < 8% in adults over 65 with multiple comorbidities, as per ADA 2024. Systolic blood pressure deemed in adequate control when < 130 mmHg, according to ADA 2024. BMI considered in control when between 18.5 and 24.9 kg/m2. LDL-C is considered in adequate control when levels are < 100 mg/dL, in accordance with ADA 2024. Albuminuria is considered negative when levels are < 30 mg/g, as per ADA 2024. FIB-4 Classification considered in control when classified within the category F0–F1

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us